Haemochromatosis Cys282Tyr mutation in pyridoxine-responsive sideroblastic anaemia

Lancet. 1997 May 17;349(9063):1475-6. doi: 10.1016/s0140-6736(05)63756-7.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Aged
  • Anemia, Sideroblastic / complications*
  • Anemia, Sideroblastic / drug therapy
  • Anemia, Sideroblastic / genetics
  • HLA Antigens / genetics
  • Hemochromatosis / complications*
  • Hemochromatosis / genetics
  • Heterozygote
  • Histocompatibility Antigens Class I / genetics
  • Humans
  • Male
  • Middle Aged
  • Point Mutation
  • Pyridoxine / administration & dosage
  • Pyridoxine / therapeutic use

Substances

  • HLA Antigens
  • Histocompatibility Antigens Class I
  • Pyridoxine